title: Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Nagore
authors.forename: Alegría
authors.initials: A
authors.lastname: Montoro
authors.forename: Silvestre
authors.initials: S
authors.lastname: Oltra
authors.forename: Eduardo
authors.initials: E
authors.lastname: Ledesma
authors.forename: Rafael
authors.initials: R
authors.lastname: Botella-Estrada
authors.forename: José M
authors.initials: JM
authors.lastname: Millán
authors.forename: Vicente
authors.initials: V
authors.lastname: Oliver
authors.forename: José M
authors.initials: JM
authors.lastname: Fortea
authors.forename: Carlos
authors.initials: C
authors.lastname: Guillén
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D051358:Cyclin-Dependent Kinase 4 / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D005260:Female; D019942:Genes, p16; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008545:Melanoma / Q000201:enzymology / Q000235:genetics*; D012878:Skin Neoplasms / Q000201:enzymology / Q000235:genetics*; D013030:Spain
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D051358:Cyclin-Dependent Kinase 4